← European Medicine Shortage Tracker · all medicines
Pomalidomid currently has availability issues reported in 4 European registers: Spain, France, Italy, Sweden.
Shortage ATC — · also listed as: POMALIDOMIDA · pomalidomide · pomalidomid · data refreshed 7 August 2026
As of 7 August 2026, 4 of the 10 tracked registers list current availability issues for Pomalidomid, covering 16 affected product presentations. The longest-running open report was filed in Sweden on 2024-12-13 and has now been open for about 20 months. Where agencies state a cause, commercial decisions or discontinuation lead with 2 of the 5 stated-cause reports, followed by manufacturing problems with 2. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-08-31. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 6 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Sweden reported first (2024-12-13), with Spain following roughly 17 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇸 Spain | Shortage POMALIDOMIDA TEVA 3 MG CAPSULAS DURAS EFG, 21 cápsulas + 2 more productsPOMALIDOMIDA TEVA 4 MG CAPSULAS DURAS EFG, 14 cápsulas POMALIDOMIDA TEVA 4 MG CAPSULAS DURAS EFG, 21 cápsulas | 2026-05-24 | 2026-09-14 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇫🇷 France | Shortage Pomalidomide Viatris 1, 2, 3 et 4 mg, gélule | — | — | Oncologie/Radiothérapie | register ↗ |
| 🇮🇹 Italy | Shortage IMNOVID + 3 more productsIMNOVID POMALIDOMIDE ACCORD POMALIDOMIDE VIATRIS | 2024-12-19 | — | Cessata commercializzazione definitiva Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
| 🇸🇪 Sweden | Shortage Pomalidomid Avansor 2 mg Kapsel, hård + 7 more productsPomalidomid Avansor 3 mg Kapsel, hård Pomalidomid Avansor 4 mg Kapsel, hård Pomalidomide Krka 1 mg Kapsel, hård Pomalidomide Teva 2 mg Kapsel, hård Pomalidomide Teva 3 mg Kapsel, hård Pomalidomide Viatris 2 mg Kapsel, hård Pomalidomide Viatris 3 mg Kapsel, hård | 2024-12-13 | 2026-12-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Pomalidomid in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | IMNOVID | Shortage | 2027-06-01 | — | Cessata commercializzazione definitiva |
| 🇮🇹 IT | IMNOVID | Shortage | 2026-12-01 | — | Cessata commercializzazione definitiva |
| 🇪🇸 ES | POMALIDOMIDA TEVA 3 MG CAPSULAS DURAS EFG, 21 cápsulas | Shortage | 2026-06-29 | 2026-09-06 | |
| 🇪🇸 ES | POMALIDOMIDA TEVA 4 MG CAPSULAS DURAS EFG, 14 cápsulas | Shortage | 2026-06-29 | 2026-09-14 | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇹 IT | POMALIDOMIDE ACCORD | Shortage | 2026-06-01 | — | Problemi produttivi |
| 🇪🇸 ES | POMALIDOMIDA TEVA 4 MG CAPSULAS DURAS EFG, 21 cápsulas | Shortage | 2026-05-24 | 2026-08-31 | |
| 🇸🇪 SE | Pomalidomide Teva 2 mg Kapsel, hård | Shortage | 2026-04-10 | 2026-10-30 | |
| 🇸🇪 SE | Pomalidomide Teva 3 mg Kapsel, hård | Shortage | 2026-04-01 | 2026-10-30 | |
| 🇸🇪 SE | Pomalidomide Krka 1 mg Kapsel, hård | Shortage | 2026-03-19 | 2026-07-27 | |
| 🇸🇪 SE | Pomalidomid Avansor 2 mg Kapsel, hård | Shortage | 2025-12-23 | 2026-12-31 | |
| 🇸🇪 SE | Pomalidomid Avansor 3 mg Kapsel, hård | Shortage | 2025-12-23 | 2026-12-31 | |
| 🇸🇪 SE | Pomalidomid Avansor 4 mg Kapsel, hård | Shortage | 2025-12-23 | 2026-12-31 | |
| 🇮🇹 IT | POMALIDOMIDE VIATRIS | Shortage | 2024-12-19 | — | Problemi produttivi |
| 🇸🇪 SE | Pomalidomide Viatris 2 mg Kapsel, hård | Shortage | 2024-12-13 | 2026-12-01 | |
| 🇸🇪 SE | Pomalidomide Viatris 3 mg Kapsel, hård | Shortage | 2024-12-13 | 2026-12-01 | |
| 🇫🇷 FR | Pomalidomide Viatris 1, 2, 3 et 4 mg, gélule | Shortage | — | — | Oncologie/Radiothérapie |
Yes. As of 7 August 2026, availability issues are reported in: Spain, France, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-08-31 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
13 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Pomalidomid: AEMPS CIMA (Spain), ANSM (France), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Pomalidomid — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pomalidomid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Pomalidomid availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pomalidomid/">Pomalidomid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>